Full Press Release Details
NOTICE OF CHANGE OF AUDITOR
| TO: | Grant Thornton LLP | |
| Crowe MacKay LLP | ||
| AND TO: | British Columbia Securities Commission | |
| Alberta Securities Commission | ||
| Financial and Consumer Affairs Authority of Saskatchewan | ||
| The Manitoba Securities Commission | ||
| Ontario Securities Commission | ||
| New Brunswick Financial and Consumer Services Commission | ||
| Nova Scotia Securities Commission | ||
| Prince Edward Island Office of the Superintendent of Securities | ||
| Superintendent of Securities (Newfoundland and Labrador) |
Notice is hereby given pursuant to Section 4.11 of National Instrument
51-102 Continuous Disclosure Obligations (NI 51-102) of a proposed change of auditor of ImmunoPrecise Antibodies Ltd. (the
DATED as of the 13th day of October, 2021.
| IMMUNOPRECISE ANTIBODIES LTD. | ||
| Per: | (signed) Lisa Helbling | |
| Name: Lisa Helbling | ||
| Title: Chief Financial Officer |